Email updates

Keep up to date with the latest news and content from BMC Musculoskeletal Disorders and BioMed Central.

Open Access Research article

Serum prolidase activity in benign joint hypermobility syndrome

Serda Em1*, Demet Ucar1, Pelin Oktayoglu1, Mehtap Bozkurt1, Mehmet Caglayan1, Ismail Yıldız2, Osman Evliyaoglu3 and Kemal Nas1

Author Affiliations

1 Department of Physical Medicine and Rehabilition, Division of Rheumatology, Dicle University Faculty of Medicine, Diyarbakir, Turkey

2 Department of Biostatistics, Dicle University Faculty of Medicine, Diyarbakir, Turkey

3 Department of Biochemistry, Dicle University Faculty of Medicine, Diyarbakir, Turkey

For all author emails, please log on.

BMC Musculoskeletal Disorders 2014, 15:75  doi:10.1186/1471-2474-15-75

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2474/15/75


Received:27 April 2013
Accepted:4 March 2014
Published:11 March 2014

© 2014 Em et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

Abstract

Background

Moderate joint laxity is widespread in many joints of the body, and this condition is considered to be caused by an abnormality in the collagen structure. This study was carried out to determine the serum prolidase activity in female patients with benign joint hypermobility syndrome (BJHS), and to evaluate its correlation with their clinical features.

Methods

A total of 45 patients with BJHS and 40 healthy controls were included in the study. All of the patients with BJHS met the Beighton diagnostic criteria. All the patients and the control group underwent a comprehensive examination of the locomotor system and took the New York Posture Rating Test. The examination and test results were recorded. Serum prolidase activity was measured in both the groups.

Results

Prolidase activity was significantly lower in patients with BJHS (479.52 ± 126.50) compared to the healthy controls (555.97 ± 128.77) (p = 0.007). We found no correlation between serum prolidase activity and Beighton scores or New York rating test scores. On the other hand, mean prolidase activity was significantly lower in patients with pes planus or hyperlordosis compared to those without (p = 0.05, p = 0.03, respectively). We did not find such a correlation with the other clinical features.

Conclusions

Significantly lower prolidase activity in patients with BJHS suggests that prolidase may affect the collagen metabolism and cause hyperlaxity.

Keywords:
Hypermobility; Prolidase; Ligament; New York rating test

Background

Benign joint hypermobility syndrome (BJHS) is a hereditary disease characterised by musculoskeletal symptoms in patients with widespread joint laxity, independent of a systemic rheumatoid disease [1]. The frequency of BJHS varies between 5–57% in young females and 2–35% in males [2]. Besides, the incidence of BJHS is higher in females compared to males and decreases with age [3]. It may develop with some musculoskeletal symptoms which are affiliated with bones, tendons, muscles, ligaments, joints and spine. Impaired stability in the joint causes pathologies in the joint because of insufficient support of the collagen connective tissue in the nonjoint [4,5].

Collagen is an abundant protein of the body. It is a major component of skin, tendons, ligaments, joint capsules and blood vessels [6]. Ligaments are dense bands of articular tissues that connect bones together. Those found in the knee are hypocellular ligaments and are composed of type I and III collagens, proteoglycans, elastin and water [7]. Maximum possible range of motion is determined by the tension of ligaments, hence by their motion restricting features. Therefore, the primary underlying cause of the hypermobility is the ligament laxity [8,9]. Reduced thickness of collagen fibrils in patients with BJHS, as suggested by the electron microscopic examination of the skin biopsy, supports this view [10].

Prolidase is an important enzyme that takes part in the collagen formation and degradation [11,12] and promotes recycling of the residues of proline, acquired from collagen degradation [13]. Prolidase deficiency affects the recycling of residues of proline in the collagen re-synthesis [14,15], consistent with the findings by some earlier studies that have reported increased prolidase activity in the fibrotic process of the liver [16], including a work in rats [17].

A study conducted in children with hypermobility reports a lower prolidase activity compared with that in control [18] although conducting a similar study is not seen in adult patients with BJHS. The presenst study involves female adult patients with BJHS. We speculate that defects in the collagen structure might be responsible for ligament laxity in patients with BJHS. Therefore we assume that prolidase deficiency might lead to a reduction in the proline content of the collagen and change the collagen structure. This study aims to evaluate the existing clinical features in patients with BJHS and compare the prolidase activity in the patients with that in the healthy controls and also investigate the correlation between prolidase and clinical features.

Methods

Study population and assessments

A total of 45 female patients of reproductive age diagnosed with joint hypermobility and 40 healthy controls were included in the study. Ethical board’s approval was obtained, patients and healthy controls were fully informed about the study, and their written consent was taken before the study was performed. Exclusion criteria were as follows: pregnancy, breastfeeding, use of oral contraceptives, menstrual irregularity and existence of any neurological, rheumatoid, skeletal, metabolic or collagen disease. Medical histories of the participants were taken. Furthermore, the participants underwent physical examinations and they were checked for routine hematologic and biochemical parameters. Physical examinations and assessments were conducted by the same team of physiatrist early in the morning, at the room temperature, with patients wearing only underwear and no shoes.

Beighton scores were used in an effort to diagnose patients with BJHS (Table 1) [19]. The lowest score was 0 and the highest score was 9. The scores at or above 4 were diagnosed as BJHS. The patients and healthy controls were assessed for the existence of joint pain, widespread pain throughout the body, carpal tunnel syndrome, joint subluxation, hyperkyphosis, hyperlordosis and pes planus. New York Posture rating test was used to assess the posture [20]. In this assessment, the patients were scored from the front, back, and sideways by observing their possible posture changes in 13 different parts of body. The participant was scored 5 if she had a straight posture, 3 if she had a moderately impaired posture and 1 if she had a severely impaired posture. The minimum total sum was 13 and maximum total sum was 65 when 13 parts were scored.

Table 1. Nine-point Beighton hypermobility score

Blood sample

Following the examination of locomotor system, the Beighton manoeuvres and the New York posture analyses, blood samples were collected from 45 consecutive females with joint hypermobility, using a cut-of value of 4 or more, and 40 healty controls at 9:00–11:00 a.m. Serum was isolated from the blood after it was kept at room temperature for 30 minutes and centrifuged at 3000 rpm for 15 minutes. Serum samples were coded and kept at -40°C for further spectrophotometric analyses.

Determination of prolidase

Activity of plasma prolidase (U/L) were determined by a spectrophotometric method that measures the proline levels produced by prolidase. The supernatant was diluted up to two folds by normal saline. Twenty-five microliters of mixture was preincubated with 75 μL preincubation solution (50 mmol/L Tris HCl buffer pH 7.0 containing 1 mmol/L glutathione and 50 mmol/L MnCl2) at 37°C for 30 minutes. The reaction mixture containing 144 mmol/L gly–pro, pH 7.8 (100 μL), was incubated with 100 μL preincubated sample at 37°C for 5 minutes. 1 mL glacial acetic acid was added to the mixture in order to cease the incubation reaction. After adding 300 μL Tris HCl buffer, pH 7.8, and 1 mL ninhydrin solution (3 g/dL ninhydrin was melted in 0.5 mol/L orthophosphoric acid), the mixture was incubated at 90°C for 20 minutes and then cooled with ice. Later on, absorbance was measured at a 515 nm wavelength to determine the proline by using the method recommended by Myara et al. [16,18]. This method is a modified version of Chinard’s method [21]. The intra-assay and interassay coefficients of variation (CVs) were both lower than 7%.

Statistical analysis

Measurement variables were expressed in mean ± standard deviation, while categorical variables were presented in numbers and percentages (%). Kolmogorow-Smirnow test was used to analyse the compliance of datasets with the normal distribution. Student-t test was used to compare the mean values of the group that displayed a normal distribution, and Mann–Whitney U test was used for the group that did not. Furthermore, Spearman’s correlation test was used to assess the correlation between serum prolidase activity and Beighton scores, New York rating test scores, joint pain, myalgia, carpal tunnel syndrome, shoulder impingement, joint subluxation, hyperkyphosis, hyperlordosis and pes planus. Varying frequencies among the categorical groups were evaluated by Chi-square test. Fisher’s exact test was used when the expected values were lower than 5. A p value below 0.05 was regarded to be statistically significant. All the analyses were performed by Statistical Package for Social Sciences software version 15.0 for Windows.

Power analysis

In this specific study, the sample size of patients and controls were determined as at least 40 according to α = 0.05 and β = 0.15. Mean serum prolidase activity were determined in the patients and controls (479.52 ± 126.50, 555.97 ± 128.77 respectively). The power of statistical analysis for study population was 0.87 according to the given effect size (population means of 479.52 vs 555.97), SD (126.50 vs 128.77), sample sizes (45 and 40), and alpha (0.050, two-tailed).

Results

We found no statistically significant difference between the two groups in terms of age, weight, height and menstrual status (p > 0.05). Mean Beighton score was significantly higher in the patients (min: 4, max: 9; mean: 6.64 ± 1.28). Mean serum prolidase activity was significantly lower in the patients (479.52 ± 126.50 pg/mL) compared to the control group (555.97 ± 128.77 pg/mL) (p = 0.007). New York Posture rating test scores were significantly lower in patients with BJHS (49.0 ± 16.2) compared to the control group (58.8 ± 3.5) (p = 0.001) (Table 2).

Table 2. Prolidase activity and demographic characteristics of the study groups (mean ± SD)

Clinical features of the patients and the controls are shown in Table 3. The frequency of joint pain (p = 0.000), myalgia (p = 0.01), shoulder impingement (p = 0.05), pes planus (p = 0.01) and hyperkyphosis was significantly higher in patients with BJHS compared to the control group. No significant difference was found between the groups with regard to the frequency of other clinical parameters (p > 0.05) (Table 3). Serum prolidase activity was significantly lower in patients with BJHS having pes planus compared to those without pes planus (p = 0.05). Furthermore, serum prolidase activity was significantly lower in patients with BJHS having hyperlordosis compared to those without hyperlordosis (p = 0.03) Table 4. No significant correlation was found between the serum prolidase activity and age, BMI, Beighton scores and New York posture test scores.

Table 3. The clinical features of study groups

Table 4. The activity of prolidase associated with clinical symptoms and findings

Discussion

Collagen is the main component of ligament structure. Prolidase is an enzyme which can influence the collagen structure in patients with BJHS. There is a study in the literature which evaluates the prolidase activity in children with hypermobility [18]. The current work is the first study to investigate the prolidase activity in adult females. The study is different from the others in two points; it has an adult target group and it establishes the correlation between prolidase and clinical features.

In this study, we found that mean serum prolidase activity was significantly lower in patients with BJHS compared to the healthy controls. Besides, the frequency of joint pain, myalgia, shoulder impingement, hyperkyphosis and pes planus was significantly higher in patients with BJHS. Serum prolidase activity was significantly lower in patients with pes planus and hyperlordosis. On the other hand, we found no significant correlation between prolidase and Beighton scores or New York posture test scores.

Benign hypermobility is a clinical syndrome characterised by greater than normal active or passive range of motion in joints, independent of a systemic rheumatoid disease. Although various enzyme and hormone studies have been conducted in this field [22,23], no full light has been shed on the etiopathogenesis of BJHS. Ligaments are hypocellular and consist of collagen, proteoglycans, elastin and water [7]. Such structural features as stiffness and flexibility of the ligament play an important role in the creation of normal joint motions. Therefore, changes in the collagen structure and the resulting ligament laxity are considered to be highly responsible for hypermobility.

Prolidase enzyme plays an important role in the regulation of collagen metabolism. Glisinprolin, a substrate of prolidase, exits in the collagen structure [24]. There are some reports stating that prolidase activity is significantly different in patients with variety of diseases where it is thought that their pathogenesis involves the pathology of collagen biosynthesis [11,25]. Significantly higher activity of prolidase is reported in patients with idiopathic clubfoot [25]. Previously, it has been found that prolidase activity is inhibited by collagen degradation products [21]. In a study, Galicka et al. [21] found lower prolidase enzyme activity in osteogenesis imperfecta cells. In another study conducted on children with joint hypermobility, who met the Beighton diagnostic criteria, Yazgan et al. [18] found lower prolidase activity in the patients compared to the controls, which was not statistically significant. Both studies concluded that decreased prolidase activity might affect the cellular growth and the collagen metabolism. Similarly, we found significantly lower prolidase activity in patients with BJHS, suggesting that prolidase might affect the collagen metabolism, partially resulting in changes in the ligament structure and paving the way for hypermobility. However, our study did not show any correlation between prolidase enzyme activity and Beighton scores. This may be attributed to the fact that the average value of scores (mean ± SD: 6.64 ± 1.28; median: 6.00) is close to the lower limit value and/or the 50% of patients have 5 and 6 scoring values.

The number of studies that have evaluated the joint and non-joint symptoms in patients with BJHS is rather limited. In their study, Mishra et al. found that 31% of the patients with BJHS had joint pain, while 10% had ligament injury, another 10% had tendinopathy and 4% had subluxation [26]. Furthermore, Shiari et al. [27] found that the frequency of joint pain was % 35.4 among patients with BJHS, whereas Yazgan et al. concluded that 30% of the children with BJHS had joint pain, 10% had pes planus and 4% had myalgia [18].

A study which investigated the postures of patients with BJHS found significant differences between the patients with BJHS and the control group with regard to posture scores and pain [28]. All the clinical signs and symptoms evaluated under this study were significantly higher and New York posture rating test scores were significantly lower in patients with BJHS. Besides, such clinical features as joint pain, myalgia, shoulder impingement and hyperkyphosis had a significant correlation with the joint laxity in these patients. Poor posture is significant in the management of BJHS, and its long term effects must be taken into account when planning a treatment for such patients. Reviewing the literature, we have not seen any study which evaluates the frequency of carpal tunnel syndrome, hyperkyphosis and hyperlordosis in patients with BJHS. Our findings support the literature with reference to the joint pain and tendinopathy. On the other hand, we found lower values than those in the literature, particularly with regard to the values found for myalgia, pes planus and subluxation. This might be attributed to the genetic variations and environmental factors.

Being a cross sectional study is one of the restrictive factors in our study. Another restrictive factor is that our study did not involve any male patients. Given the fact that hypermobility is more prevalent among females, we could not find enough number of male patients and excluded this group from the study. Not considering the possible factors affecting prolidase activity may be another limitation of the present study.

Conclusions

Prolidase is an important enzyme that takes part in the collagen formation and degradation. It is particularly influential in the last stage where the imminopeptidases which contain C-terminal proline and hyroxyproline split. We performed this study with assumption of a possible correlation between collagen defects and serum prolidase activity in patients with BJHS. We found that serum prolidase activity was significantly lower in the patients compared to the healthy controls. Therefore, we suggest that the lower serum prolidase activity may be an important etiologic factor in the etiopathogenesis of BJHS. However, in order to attain further knowledge about the role of prolidase in joint and the process of the disease, more comprehensive studies on a wider range of population are required.

Competing interests

The authors’ declare that they have no competing interest.

Authors’ contributions

SE was the main investigator and involved in the study design, data collection, analysis and drafting of the manuscript. DU was involved in the study design, data analysis, and providing the final draft. PO contributed to the idea, study design, data analysis and, drafting of the manuscript. MB was involved in the study design, and data analysis. MC was participated in the data analysis and, drafting of the manuscript. IY data contributed to analysis and interpretation. OE involved in the study design, and data analysis. KN was participated critical revision of the article. All authors read and approved the final manuscript.

References

  1. Grahame R: Hypermobility syndrome. In Rheumatology. Edited by Klippel JH, Dieppe PA. London: Mosby; 1997.

    5.18.1-5.18.6

    OpenURL

  2. Hakim A, Grahame R: Joint hypermobility.

    Best Pract Res Clin Rheumatol 2003, 17:989-1004. PubMed Abstract | Publisher Full Text OpenURL

  3. Grahame R: The hypermobility syndrome.

    Ann Rheum Dis 1990, 49:199-200. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  4. Simpson MR: Benign Joint Hypermobility Syndrome: Evaluation, Diagnosis, and Management.

    J Am Osteopath Assoc 2006, 106:531-536. PubMed Abstract | Publisher Full Text OpenURL

  5. Grahame R: Pain, distress and joint hyperlaxity.

    Joint, Bone Spine 2000, 67:157-163. PubMed Abstract OpenURL

  6. Westling L, Holm S, Wallentin I: Temporomandibular joint dysfunction: Connective tissue variations in skin biopsy and mitral valve function.

    Oral Surg Oral Med Oral Pathol 1992, 74:709-718. PubMed Abstract | Publisher Full Text OpenURL

  7. Hart DA, Scıore P, Boykiw R, Reno C: Pregnancy induces complex changes in the pattern of mRNA expression in knee ligaments of the adolescent rabbit.

    Matrix Biol 1998, 17:21-34. PubMed Abstract | Publisher Full Text OpenURL

  8. Bird HA: Joint hypermobility Musculoskelet.

    Care 2007, 5:4-19. OpenURL

  9. Grahame R: Joint hypermobility and genetic collagen disorders: are they related?

    Arch Dis Child 1999, 80:188-191. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  10. Handler CE, Child A, Light ND, Dorrance DE: Mitral valve prolapse, aortic compliance, and skin collagen in jointhypermobility syndrome.

    Br Heart J 1985, 54:501-508. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  11. Vural M, Toy H, Camuzcuoglu H, Aksoy N: Comparison of prolidase enzyme activities of maternal serum and placental tissue in patients with early pregnancy failure.

    Arch Gynecol Obstet 2010, 283:953-958. PubMed Abstract | Publisher Full Text OpenURL

  12. Lupi A, Rossi A, Vaghi P, Gallanti A, Cetta G: N-benzyloxycarbonyl-l-proline. an in vitro and in vivo inhibitor of prolidase.

    Biochim Biophys Acta 2005, 1744:157-163. PubMed Abstract | Publisher Full Text OpenURL

  13. Altay MA, Erturk C, Aksoy N, Taskin A, Bilge A, Celik H, Isikan UE: Serum prolidase activity and oxidative-antioxidative status in Legg-Calve-Perthes disease.

    J Pediatr Orthop B 2011, 20:222-226. PubMed Abstract | Publisher Full Text OpenURL

  14. Jackson SH, Dennis AN, Greenberg M: Iminopeptiduria a genetic defect in recycling collagen: a method for determining prolidase in red blood cells.

    Can Med Ass J 1975, 113:759-763. PubMed Abstract | PubMed Central Full Text OpenURL

  15. Jackson SH, Heininger JA: A reassessment of the collagen reutillization theory by an isotope ratio method.

    Clin Chim Acta 1973, 46:153-160. PubMed Abstract | Publisher Full Text OpenURL

  16. Myara I, Miech G, Fabre M, Mangeot M, Lemonnier A: Changes in prolinase and prolidase activity during CCl4 administration inducing liver cytolysis and fibrosis in rat.

    Br J Exp Pathol 1987, 68:7-13. PubMed Abstract | PubMed Central Full Text OpenURL

  17. Abraham P, Wilfred G, Ramakrishna B: Plasma prolidase may be an index of liver fibrosis in the rat.

    Clin Chim Acta 1997, 295:199-202. OpenURL

  18. Yazgan P, Geyikli I, Zeyrek D, Baktiroglu L, Kurcer MA: Is joint hypermobility important in prepubertal children?

    Rheumatol Int 2008, 28:445-451. PubMed Abstract | Publisher Full Text OpenURL

  19. Grahame R: The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS).

    J Rheumatol 2000, 27:1177-1178. OpenURL

  20. Magee DJ: Orthopedic Physical Assessment. In Gait Assessment. 13th edition. Toronto: W.B.Saunders Company; 1987:362-376. OpenURL

  21. Galicka A, Wolczynskis S, Anchim T, Surazynski A, Lesniewicz R, Palka J: Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta.

    Eur J Biochem 2001, 268:2172-2178. PubMed Abstract | Publisher Full Text OpenURL

  22. Denko CW, Boja B: Growth hormone, insulin, and insulin-like growth factor-1 in hypermobility syndrome.

    J Rheumatol 2001, 28:1666-1669. PubMed Abstract | Publisher Full Text OpenURL

  23. Pokorny MJ, Smith TD, Calus SA, Dennison EA: Self-reported oral contraceptive use and peripheral joint laxitys.

    J Orthop Sports Phys Ther 2000, 30:683-692. PubMed Abstract | Publisher Full Text OpenURL

  24. Reid KBM, Porter RR: A collagen-like amino acid sequencein a polypeptide chain of human C1q (a subcomponent of the fi rst component of complement).

    Biochem J 1976, 155:19-23. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  25. Altay MA, Erturk C, Aksoy N, Taskın A, Isıkan UE: A preliminary study pointing out the role of serum prolidase activity and oxidative-antioxidative status parameters during the treatment process of patients with idiopathic clubfoot.

    Scand J Clin Lab Invest 2011, 71:576-82. PubMed Abstract | Publisher Full Text OpenURL

  26. Mishra MB, Ryan P, Atkinson P, Taylor H, Bell J, Calver D, Fogelman L, Child A, Jackson G, Chambers JB, Grahame R: Extra-articular features of benign joint hypermobility syndrome.

    Br J Rheumatol 1996, 35:861-866. PubMed Abstract | Publisher Full Text OpenURL

  27. Shiari R, Vaziri F, Javaherizadeh H, Zahmatkesh E, Torabizadeh M, Zadkarami M, Nezhad-Biglari H: Association of benign joint hypermobility syndrome with mitral valve prolapse in Iranian children.

    HK J Paediatr 2012, 17:115-118. OpenURL

  28. Booshanam DS, Cherian B, Joseph CP, Mathew J, Thomas R: Evaluation of posture and pain in persons with benign joint hypermobility syndrome.

    Rheumatol Int 2011, 31:1561-1565. PubMed Abstract | Publisher Full Text OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2474/15/75/prepub